D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice

Journal of Lipid Research

Volumn 53, Issue 3, 2012, Pages 437-445

  Navab, Mohamad ^a   Reddy, Srinivasa T ^a   Anantharamaiah, G M ^b   Hough, Greg ^a   Buga, Georgette M ^a   Danciger, Jan ^a   Fogelman, Alan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Apolipoprotein A I; Apolipoprotein A I mimetic peptides; Hydroxyeicosatetraenoic acid; Hydroxyoctadecadienoic acid; Lipoproteins; Small intestine

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; ACETYLASPARTYLTRYPTOPHANYLPHENYLALANYLLYSYLALANYLPHENYLALANYLTYROSYLASPARTYLLYSYLVALYLALANYLGLUTAMYLLYSYLPHENYLALANYLLYSYLGLUTAMYLALANYLPHENYLALANINEAMIDE; ARACHIDONIC ACID; ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN RECEPTOR; PEPTIDOMIMETIC AGENT; SERUM AMYLOID A; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BILE; BINDING AFFINITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG LIVER LEVEL; ENZYME ACTIVITY; FATTY ACID METABOLISM; FEMALE; INFLAMMATION; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMALL INTESTINE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEIN A-I; ARACHIDONIC ACID; BILE; FEMALE; INFLAMMATION; INTESTINE, SMALL; LINOLEIC ACIDS; LIVER; MICE; MICE, KNOCKOUT; RECEPTORS, LDL;

EID: 84857697043     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M023523     Document Type: Article

References (24)

1. Navab, M., S. T. Reddy, G. M. Anantharamaiah, S. Imaizumi, G. Hough, S. Hama, and A. M. Fogelman. 2011. Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally. J. Lipid Res. 52: 1200-1210.
2. Van Lenten, B. J., A. C. Wagner, C. L. Jung, P. Ruchala, A. J. Waring, R. I. Lehrer, A. D. Watson, S. Hama, M. Navab, G. M. Anantharamaiah, et al. 2008. Anti-inflammatory apoA-I mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J. Lipid Res. 49: 2302-2311.
3. Imaizumi, S., V. Grijalva, M. Navab, B. J. Van Lenten, A. C. Wagner, G. M. Anantharamaiah, A. M. Fogelman, and S. T. Reddy. 2010. L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice. Drug Metab. Lett. 4: 139-148.
4. Morgantini, C., S. Imaizumi, V. Grijalva, M. Navab, A. M. Fogelman, and S. T. Reddy. 2010. ApoAI mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a mouse model of diabetes. Diabetes. 59: 3223-3228.
5. Morgantini, C., A. Natali, B. Boldrini, S. Imaizumi, M. Navab, A. M. Fogelman, E. Ferrannini, and S. T. Reddy. 2011. Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes. Diabetes. 60: 2617-2623.
6. Navab, M., G. M. Anantharamaiah, S. T. Reddy, S. Hama, G. Hough, V. R. Grijalva, A. C. Wagner, J. S. Frank, G. Datta, D. Garber, et al. 2004. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation. 109: 3215-3220.
7. Navab M., P. Ruchala, A.J. Waring, R.I. Lehrer, S. Hama, G. Hough, M.N. Palgunachari, G.M. Anantharamaiah, and A.M. Fogelman. 2009. A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. J. Lipid Res. 50: 1538-1547.
8. Merchant, J. L., and R. A. Heller. 1977. 3-Hydroxy-3-methylglutaryl coenzyme A reductase in isolated villous and crypt cells of the rat ileum. J. Lipid Res. 18: 722-733. (Pubitemid 8238668)
9. Buga, G. M., M. Navab, S. Imaizumi, S. T. Reddy, B. Yekta, G. Hough, S. Chanslor, G. M. Anantharamaiah, and A. M. Fogelman. 2010. L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation. Arterioscler. Thromb. Vasc. Biol. 30: 283-289.
10. Bloedon, L. T., R. Dunbar, D. Duffy, P. Pinell-Salles, R. Norris, B. J. DeGroot, R. Movva, M. Navab, A. M. Fogelman, and D. J. Rader. 2008. Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients. J. Lipid Res. 49: 1344-1352.
11. Watson, C. E., N. Weissbach, L. Kjems, S. Ayalasomayajula, Y. Zhang, I. Chang, M. Navab, S. Hama, G. Hough, S. T. Reddy, et al. 2011. Treatment of patients with cardiovascular disease with L-4F, an apoA-1 mimetic, did not improve select biomarkers of HDL function. J. Lipid Res. 52: 361-373.
12. Dobrian, A. D., D. C. Lieb, B. K. Cole, D. A. Taylor-Fishwick, S. K. Chakrabarti, and J. L. Nadler. 2011. Functional and pathological roles of the 12- and 15-lipoxygenases. Prog. Lipid Res. 50: 115-131.
13. Di Mari, J. F., J. I. Saada, R. C. Mifflin, J. D. Valentich, and D. W. Powell. 2007. HETEs enhance IL-1-mediated COX-1 expression via augmentation of message stability in human colonic myofibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G719-G728. (Pubitemid 47610418)
14. Oleksiak, M. F., S. Wu, C. Parker, W. Qu, R. Cox, D. C. Zeldin, and J. J. Stegeman. 2003. Identification and regulation of a new vertebrate cytochrome P450 subfamily, CYP2Ps, and functional characterization of CYP2P3, a conserved arachidonic acid epoxygenase/19-hydroxylase. Arch. Biochem. Biophys. 411: 223-234. (Pubitemid 36298650)
15. Wegmann, M., A. Kampen, S. Weber, H. W. Seyberth, and A. Kockerling. 2000. Effect of hydroxyeicosatetraenoic acids on furosemide- sensitive chloride secretion in rat distal colon. J. Pharmacol. Exp. Ther. 295: 133-138.
16. De Lisle, R. C., L. Meldi, M. Flynn, and K. Jansson. 2008. Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine. J. Pediatr. Gastroenterol. Nutr. 47: 406-416.
17. Mangino, M.J., C.B. Anderson, M.K. Murphy, E. Brunt, J. Turk. 1989. Mucosal arachidonate metabolism and intestinal ischemia-reperfusion injury. Am. J. Physiol. (Gastrointest. Liver Physiol. 20); 257: G299-G307.
18. Kamitani, H., H. Ikawa, L. C. Hsi, T. Watanabe, R. N. DuBois, and T. E. Eling. 1999. Regulation of 12-lipoxygenase in rat intestinal epithelial cells during differentiation and apoptosis induced by sodium butyrate. Arch. Biochem. Biophys. 368: 45-55. (Pubitemid 29372303)
19. Krilis, S. A., J. L. Macpherson, D. J. de Carle, G. E. Daggard, N. A. Talley, and C. N. Chesterman. 1986. Small bowel mucosa from celiac patients generates 15-hydroxyeicosatetraenoic acid (15-HETE) after in vitro challenge with gluten. J. Immunol. 137: 3768-3771. (Pubitemid 17215299)
20. Morgan, A. H., V. Dioszeghy, B. H. Maskery, C. P. Thomas, S. R. Clark, S. A. Mathie, C. M. Lloyd, H. Kuhn, N. Topley, B. C. Coles, et al. 2009. Phosphatidlyethanolamine-esterified eicosanoids in the mouse. Tissue localization and inflammation-dependent formation in Th-2 disease. J. Biol. Chem. 284: 21185-21191.
21. Collins, J. F., Z. Hu, P. N. Ranganathan, D. Feng, L. M. Garrick, M. D. Garrick, and R. W. Browne. 2008. Induction of arachidonate 12- lipoxygenase (Alox 15) in intestine of iron-deficient rats correlates with the production of biologically active lipid mediators. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G948-G962.
22. Adler, D. H., J. A. Phillips III, J. D. Cogan, T. M. Iverson, N. Schnetz- Boutaud, J. A. Stein, D. A. Brenner, G. L. Milne, J. D. Morrow, O. Boutaud, et al. 2009. The enteropathy of prostaglandin deficiency. J. Gastroenterol. 44 (Suppl 19) : 1-7.
23. Brunham, L. R., J. K. Kruit, J. Iqbal, C. Fievet, J. M. Timmins, T. D. Pape, B. A. Coburn, N. Bissada, B. Staels, A. K. Groen, et al. 2006. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 116: 1052-1062.
24. Meriwether, D., S. Imaizumi, V. Grijalva, G. Hough, L. Vakili, G. M. Anantharamaiah, R. Farias-Eisner, M. Navab, A. M. Fogelman, S. T. Reddy, et al. 2011. Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma. J. Lipid Res. 52: 1795-1809